ArticlePloS one2017

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

Francesco Trotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.